SITC Resource Library

Targets for Cancer IO: A Deep Dive, TCR based Therapeutics 

12-12-2022 10:54

This is the library for the Enduring Materials from the Targets for Cancer IO: A Deep Dive, TCR based therapies webinar that was conducted on December 7, 2022.

  • Date of Live Event: Wednesday, Dec. 7, 2022 – 2 p.m.–4 p.m. CST
  • Moderators:
    • Harlan Robins, PhD – Adaptive Biotechnologies Corporation
  • Faculty:
    • David Berman, MD, PhD - Immunocore
    • Aude Chapuis, MD - Fred Hutchinson Cancer Center
    • Ira Mellman, PhD - Genentech

Targets for Cancer IO: A Deep Dive Series 2 is supported, in part, by educational grants from:



Interested in supporting this program? The SITC Development team would love to work with you. Contact Development@sitcancer.org for more information on how your organization's support can help advance cancer immunotherapy and make "cure" a reality.

#ClinicalTrials
#Tcells
#RecordedWebinar
#TargetsforCancerImmunotherapyADeepDiveSeminarSeries
#Industry
#Clinician
#Oncologist
#Researcher
#2022

Statistics
0 Favorited
80 Views
1 Files
0 Shares
26 Downloads
Attachment(s)
mp4 file
Targets in Cancer Immunotherapy_ A Deep Dive, TCR based T....mp4   2.58 GB   1 version
Uploaded - 12-12-2022
Meeting: 2022 Targets in Cancer IO: A Deep Dive in TCR based Therapies; Moderator: Harlan Robins, PhD – Adaptive Biotechnologies Corporation; Faculty: David Berman, MD, PhD - Immunocore,Aude Chapuis, MD - Fred Hutchinson Cancer Center, Ira Mellman, PhD - Genentech

Related Entries and Links

No Related Resource entered.